Cancer & Disease Screening

These are the tests in an executive health package that are not about longevity at all — they are conventional disease screening, riding along in the same invoice. That matters, because screening is the one area where the evidence is unusually well settled: national bodies have argued about these exact tests for decades and published explicit recommendations either way. The result is the widest grade spread on the site — the cheapest test here is also one of the best evidenced, and several of the most reassuringly-named ones are recommended against outright.

• Strong Faecal Immunochemical Test (FIT)A stool sample, collected at home, tested for blood invisible to the eye. S$10–30 standalone; subsidised for eligible citizens and PRs under Singapore's national Screen for Life programmePrice guide →
• Moderate Prostate-Specific Antigen (PSA)The most argued-about blood test in preventive medicine, and the argument is not resolvable by picking a side. S$30–60Price guide →
• Weak Tumour Marker Panel (CEA, AFP, CA 19-9, CA 125, CA 15-3)The most misleading line on a Singapore executive health invoice. S$150–400 for a five- to seven-marker panel
• Moderate EBV Testing for Nasopharyngeal CancerA test whose value depends almost entirely on where you live and whose ancestry you have. S$40–90 (IgA serology); plasma EBV DNA testing is less widely offered and costs more
• Strong Screening MammographyOffered as one of the “choose two” imaging options in most women's executive packages, which badly understates it. S$100–250 standalone; subsidised for eligible women under Singapore's Screen for Life programme
• Weak Tonometry (Glaucoma Screening)The puff-of-air test, included in most executive packages as a “glaucoma screen”. S$20–50 (usually absorbed into the package price)
• Emerging Multi-Cancer Early Detection Blood TestsA single blood draw claiming to detect dozens of cancers by reading fragments of tumour DNA shed into the bloodstream… S$1,200–2,500